Novartis Investigative Site

Zaragoza, Zaragoza 50009

0 studies enrolling now · 4 studies all time

What they study most

Adenocarcinoma, Breast Cancer, Carcinoma, HER2/Neu Over-expressing Locally Advanced Breast Cancer, Hypernephroid, Metastatic Breast Cancer, Nephroid Carcinoma, Renal Cell

Studies at this site

• Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer — Completed
• Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer — Completed
• A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation — Completed
• Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer — Completed